A condition that has killed at least 50 people in northwest Democratic Republic of Congo this month is suspected to be malaria or food poisoning, local health officials said on Thursday. At least 943 ...

A world-first clinical trial will investigate whether the experimental treatment given to a former Australian of the year can ...

Planning Activities Are Ongoing for Next Phase of Cemsidomide Clinical Development in Multiple Myeloma and Non-Hodgkin’s Lymphoma; Trials ...

"You go to the playground and kids are running around, parents are saying, ‘oh my kids are nuts, can’t control them,’" Drew ...

Plus Therapeutics, Inc. (Nasdaq: PSTV) (the "Company" or "Plus Therapeutics"), a clinical-stage pharmaceutical company developing targeted radiotherapeutics ...

Plus Therapeutics, Inc. (Nasdaq: PSTV) (the “Company” or “Plus Therapeutics”), a clinical-stage pharmaceutical company developing targeted radiotherapeutics with advanced platform technologies for ...

AI in Robotic Platforms Market size is expected to reach USD 313.1 billion by 2034, projected at a CAGR of 33.9% during ...

InnoCare Pharma (HKEX: 09969; SSE: 688428), a leading biopharmaceutical company focusing on the treatment of cancer and autoimmune diseases, announced today that the phase II results of orelabrutinib ...

Qure's stock rises on Huntington's therapy progress and strong gene therapy pipeline. Learn about QURE stock's cost-cutting ...

Quantum systems researchers at Birmingham are opening new avenues in brain imaging and diagnostics by exploiting the ...

Rather than calling real estate development or any industry “male-dominated” and viewing the numbers in a negative light, ...

KOL Event on aneurysmal Subarachnoid Hemorrhage (aSAH) ...